서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 19 of 19

Issue DateTitle / Author(s) / CitationFileAltmetrics
2002
The Treatment of severe aplastic anemia : the outcomes of bone marrow transplantation and immunosuppressive therapy in Koreans
link
2007
Pneumatosis intestinalis with pneumoperitoneum mimicking intestinal perforation in a patient with myelodysplastic syndrome after hematopoietic stem cell transplantation

Keam, Bhumsuk; Lee, Jeong-Hoon; Oh, Myoung-Don; Kim, Inho; Yoon, Sung-Soo; Kim, Byoung Kook; Park, Seonyang

The Korean Journal of Internal Medicine 22(1):40-44.

link
2007-04
Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning
view filelink
2007-05
Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation
link
2008-06
Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea
link
2009
Clinical predictors of recurrent venous thromboembolism A single institute experience in Korea
DOI
2009-02
Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer
DOI
2009-11
Patients with Hematologic Malignancies May Be at Higher Risk of Hepatitis B Reactivation in Spite of Lamivudine Prophylaxis
2009-11
Hypoplastic Myelodysplastic Syndrome (h-MDS) Is a Distinctive Clinical Entity with Poorer Prognosis and Frequent Karyotypic and FISH Abnormalities Compared to Aplastic Anemia (AA)
2009-11
Prognosis of Secondary Acute Myeloid Leukemia Is Affected by the Type of the Preceding Hematologic Disorders and the Presence of Trisomy 8
2010-01
Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
DOI
2010-05
Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
view fileDOI
2010-11
Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML.
2010-11
Allogeneic Stem Cell Transplantation (alloSCT) and Donor Lymphocyte Infusion (DLI) In Patients with Non-Hodgkin Lymphoma (NHL) Who Experienced Relapse or Progression After Autologous Stem Cell Transplantation (autoSCT): Retrospective Analysis From the Korean Society of Blood and Marrow Transplantation.
2010-11
Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21).
2010-11
Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
view fileDOI
2019-05
Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte
view fileDOI
2021-01
Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
view fileDOI
1